Education
About Us
Working with TipRanks
Follow Us
INVO Fertility (IVF)
NASDAQ:IVF
IVF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.61 - $51.08
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.47M
Market Cap
$1.68M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.53
Shares Outstanding928,272
10 Day Avg. Volume7,010,053
30 Day Avg. Volume2,465,109
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.00Price Target Upside-43.82% Downside
Rating ConsensusHold
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Market PositioningThe company's portfolio is composed of bifunctional antibodies, which are gaining rapid interest and substantial capital inflows due to positive data, especially in solid tumors.
Product DevelopmentNAYA Biosciences has the potential to become a significant player in first and second-line treatments for hepatocellular carcinoma by 2028.
Strategic PartnershipsThe merger of INVO Biosciences with NAYA Biosciences creates a strong focus on developing a portfolio of bifunctional antibodies.
Bears Say
Business FocusThe inability of the strategy to shift focus to oncology in general and bispecifics in particular is a disappointment, in our view.
Financial StrategyRaising capital will likely take time in a particularly challenging market environment.
Regulatory ComplianceThe company received a letter from Nasdaq indicating that the company failed to file its 10-K on a timely basis and as such, no longer satisfies listing rules.
INVO Fertility News
IVF FAQ
What was INVO Fertility’s price range in the past 12 months?
INVO Fertility lowest stock price was $1.61 and its highest was $51.08 in the past 12 months.
What is INVO Fertility’s market cap?
INVO Fertility’s market cap is $1.68M.
When is INVO Fertility’s upcoming earnings report date?
INVO Fertility’s upcoming earnings report date is Aug 18, 2025 which is in 17 days.
How were INVO Fertility’s earnings last quarter?
INVO Fertility released its earnings results on May 20, 2025. The company reported -$12.53 earnings per share for the quarter, missing the consensus estimate of N/A by -$12.53.
Is INVO Fertility overvalued?
According to Wall Street analysts INVO Fertility’s price is currently Overvalued.
Does INVO Fertility pay dividends?
INVO Fertility does not currently pay dividends.
What is INVO Fertility’s EPS estimate?
INVO Fertility’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Fertility have?
INVO Fertility has 928,272 shares outstanding.
What happened to INVO Fertility’s price movement after its last earnings report?
INVO Fertility reported an EPS of -$12.53 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.398%.
Which hedge fund is a major shareholder of INVO Fertility?
Currently, no hedge funds are holding shares in IVF
Company Description
INVO Fertility
INVO Fertility (IVF) is a company operating in the fertility and reproductive health sector. It is dedicated to providing innovative and cost-effective solutions for individuals and couples seeking fertility treatment. The company's core product is the INVOcell, an FDA-cleared medical device that allows fertilization and early embryo development to occur within the woman's body, offering a more natural and less expensive alternative to traditional in vitro fertilization (IVF) procedures.
Technical Analysis
Helius Medical Technologies
―
Catheter Precision
―
Bluejay Diagnostics
―
Tivic Health Systems
―
Ownership Overview
―
Insiders
0.21%
Mutual Funds
5.15% Other Institutional Investors
94.43% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---